Capella Bioscience Ltd: Clinical Trials

1 trial sponsored by Capella Bioscience Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Capella Bioscience Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
CBS001, Placebo - Chronic Inflammatory Disease
Phase 1TerminatedCapella Bioscience Ltd562022-04-142023-09-22

Countries

United Kingdom (1)